Jaguar Health (JAGX) Net Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) Net Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 9,283.00 |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 506.00 |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -569.00 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | -471.00 |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 7,218.00 |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 8,668.00 |
| Jun 30, 2025 | -3,380.00 |
| Mar 31, 2025 | 8.95 Mn |
| Dec 31, 2024 | 39,647.00 |
| Sep 30, 2024 | 166,001.00 |
| Jun 30, 2024 | 336,646.00 |
| Mar 31, 2024 | 60,169.00 |
| Dec 31, 2023 | 4,245.00 |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 7.52 Mn |
| Mar 31, 2023 | -2.61 Mn |
| Dec 31, 2022 | -2.32 Mn |
| Sep 30, 2022 | 80,110.00 |
| Jun 30, 2022 | 65,945.00 |
| Mar 31, 2022 | -8.94 Mn |
| Dec 31, 2021 | 4,244.00 |
| Sep 30, 2021 | -144,021.00 |
| Jun 30, 2021 | -273,638.00 |